Sujal Shah

Insider Reports History

Location
Newark, CA
Signature
/s/ Dan Conn, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sujal Shah:

Company Role Class Num Shares Value Price $ Report Date Ownership
CymaBay Therapeutics, Inc. Chief Executive Officer, Director Common Stock 0 $0 $2.94 22 Mar 2024 Direct
Tvardi Therapeutics, Inc. Director Stock Option (right to buy) 12,000 17 Apr 2025 Direct
CymaBay Therapeutics, Inc. Chief Executive Officer, Director Stock Appreciation Right 0 11 Dec 2023 Direct
CymaBay Therapeutics, Inc. Chief Executive Officer, Director Employee Stock Option (right to buy) 0 22 Mar 2024 Direct

Insider Reports Filed by Sujal Shah

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TVRD Tvardi Therapeutics, Inc. 17 Apr 2025 1 $0 4 Director 21 Apr 2025, 17:15
TVRD Tvardi Therapeutics, Inc. 15 Apr 2025 2 $0 4 Director 17 Apr 2025, 18:50
TVRD Tvardi Therapeutics, Inc. 15 Apr 2025 0 $0 3 Director 17 Apr 2025, 18:19
/report/000095017024035447-shah-sujal-2024-03-22 CymaBay Therapeutics, Inc. 22 Mar 2024 15 $0 4 Chief Executive Officer, Director 22 Mar 2024, 16:55
/report/000106299324006513-shah-sujal-2024-03-13 CymaBay Therapeutics, Inc. 13 Mar 2024 18 +$655,959 4 Chief Executive Officer, Director 15 Mar 2024, 16:03
/report/000106299324001426-shah-sujal-2024-01-24 CymaBay Therapeutics, Inc. 24 Jan 2024 2 $0 4 Chief Executive Officer, Director 26 Jan 2024, 18:27
/report/000106299323022368-shah-sujal-2023-12-11 CymaBay Therapeutics, Inc. 11 Dec 2023 7 -$972,845 4 Chief Executive Officer, Director 11 Dec 2023, 19:03
/report/000106299323020835-shah-sujal-2023-11-13 CymaBay Therapeutics, Inc. 13 Nov 2023 7 -$706,345 4 Chief Executive Officer, Director 14 Nov 2023, 18:00
/report/000106299323019205-shah-sujal-2023-10-09 CymaBay Therapeutics, Inc. 09 Oct 2023 5 -$596,981 4 Chief Executive Officer, Director 10 Oct 2023, 17:04
/report/000106299323001493-shah-sujal-2023-01-25 CymaBay Therapeutics, Inc. 25 Jan 2023 1 $0 4 Chief Executive Officer, Director 27 Jan 2023, 15:27
/report/000106299322014432-shah-sujal-2022-06-06 CymaBay Therapeutics, Inc. 06 Jun 2022 1 +$100,037 4 Chief Executive Officer, Director 07 Jun 2022, 08:14
/report/000106299322001697-shah-sujal-2022-01-25 CymaBay Therapeutics, Inc. 25 Jan 2022 1 $0 4 Chief Executive Officer, Director 27 Jan 2022, 15:55